Federal Securities Law Blog
Illegal Insider Trading and the Healthcare Industry
The SEC announced yesterday charges against a former Citigroup investment banker who allegedly tipped his friends and family about upcoming mergers involving Citigroup’s healthcare industry clients, resulting in more than $5,000,000 in illegal insider-trading profits.
The case highlights a common insider-trading scenario: an employees uses inside information not to trade stock in his or her employer, but rather to trade stock in the employer’s clients.
In particular, privately-owned companies tend to think of illegal insider trading as a public-company problem, but often private companies and their employees are privy to information about public-company clients that can lead to insider trading concerns.
For example, the healthcare industry has a strong support industry of researchers, policy analysts, consultants, lobbyists, etc., all of whom potentially have access to material non-public information from their public healthcare clients that can be used to engage in illegal insider trading.
This raises a host of issues for private companies that service public companies, including:
- Should we have a company policy regarding employees owning stock in our clients?
- Should we accept stock as payment for services?
- If an employee who knows a lot about the industry makes great stock picks in client stock, will it seem like illegal insider trading even if technically it is not?
- If an employee pieces together a series of seemingly inconsequential non-public information and trades stock based on that information, what are the chances he or she will be accused of illegal insider trading?
- Is there a difference between having a hunch something good will happen to the client’s stock and knowing something good will happen?
- May an employee trade stock based on information that is technically publicly available (or would be provided by the client upon request) but was never actually in a press release?
These issues become more important as the SEC continues to step up enforcement.
http://www.fedseclaw.com/admin/trackback/128618
Suite 2200
Cincinnati, OH 45202-5118
Phone: 513-381-4700
Toll Free: 800-582-5813
Fax: 513-421-0991
Suite 1700
Cleveland, OH 44115-1483
Phone: 216-443-9000
Toll Free: 800-824-1980
Fax: 216-443-9011
41 South High Street
Columbus, OH 43215-6194
Phone: 614-227-2000
Toll Free: 800-533-2794
Fax: 614-227-2100
Suite 1600
One South Main Street
Dayton, OH 45402-2028
Phone: 937-449-6810
Toll Free: 800-533-4434
Fax: 937-449-6820
Third Floor
Naples, FL 34108-2683
Phone: 239-593-2900
Toll Free: 800-876-7962
Fax: 239-593-2990
NW, Suite 500
Washington, DC 20006-3434
Phone: 202-778-3000
Toll Free: 800-456-7962
Fax: 202-778-3063